Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
This listing combines 10 mg tesamorelin with 3 mg ipamorelin. The ingredients engage different growth hormone release pathways: GHRH receptor signaling and ghrelin receptor signaling. The blend may be characterized for combined endocrine responses.
Key research interests
• Combined growth hormone release pathways
• GHRH and ghrelin receptor signaling
• Blend characterization
Not for human or veterinary use
This listing combines 10 mg tesamorelin with 3 mg ipamorelin. The ingredients engage different growth hormone release pathways: GHRH receptor signaling and ghrelin receptor signaling. The blend may be characterized for combined endocrine responses.
Key research interests
• Combined growth hormone release pathways
• GHRH and ghrelin receptor signaling
• Blend characterization
Not for human or veterinary use